{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T15:29:13Z","timestamp":1792250953251,"version":"4.4.0"},"reference-count":38,"publisher":"Japanese Society of Veterinary Science","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Vet. Med. Sci.","The Journal of Veterinary Medical Science"],"published-print":{"date-parts":[[2022]]},"DOI":"10.1292\/jvms.21-0479","type":"journal-article","created":{"date-parts":[[2022,2,7]],"date-time":"2022-02-07T22:08:30Z","timestamp":1644271710000},"page":"445-453","source":"Crossref","is-referenced-by-count":22,"title":["Recommended doses of medetomidine-midazolam-butorphanol with atipamezole for preventing hypothermia in mice"],"prefix":"10.1292","volume":"84","author":[{"given":"Mizuho","family":"TASHIRO","sequence":"first","affiliation":[{"name":"Laboratory of Experimental Animal Science, Nippon Veterinary and Life Science University, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"TOHEI","sequence":"additional","affiliation":[{"name":"Laboratory of Experimental Animal Science, Nippon Veterinary and Life Science University, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"122","reference":[{"key":"1","unstructured":"1. Arras, M., Autenried, P., Rettich, A., Spaeni, D. and R\u00fclicke, T. 2001. Optimization of intraperitoneal injection anesthesia in mice: drugs, dosages, adverse effects, and anesthesia depth. <i>Comp. Med.<\/i> 51: 443\u2013456."},{"key":"2","unstructured":"2. Baker, N. J., Schofield, J. C., Caswell, M. D. and McLellan, A. D. 2011. Effects of early atipamezole reversal of medetomidine-ketamine anesthesia in mice. <i>J. Am. Assoc. Lab. Anim. Sci.<\/i> 50: 916\u2013920."},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Cruz, J. I., Loste, J. M. and Burzaco, O. H. 1998. Observations on the use of medetomidine\/ketamine and its reversal with atipamezole for chemical restraint in the mouse. <i>Lab. Anim.<\/i> 32: 18\u201322.","DOI":"10.1258\/002367798780559383"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Flecknell, P. A. 2016. Analgesia and post-operative care, p. 182. In: Laboratory Animal Anaesthesia, 4th ed., Elsevier, Waltham.","DOI":"10.1016\/B978-0-12-800036-6.00004-1"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Flecknell, P. A. 2016. Basic principles of anaesthesia, pp. 51\u201366. In: Laboratory Animal Anaesthesia, 4th ed., Elsevier, Waltham.","DOI":"10.1016\/B978-0-12-800036-6.00001-6"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Flecknell, P. A. 2016. Managing and monitoring anaesthesia, pp. 92\u2013107. In: Laboratory Animal Anaesthesia, 4th ed., Elsevier, Waltham.","DOI":"10.1016\/B978-0-12-800036-6.00002-8"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Fleischmann, T., Jirkof, P., Henke, J., Arras, M. and Cesarovic, N. 2016. Injection anaesthesia with fentanyl-midazolam-medetomidine in adult female mice: importance of antagonization and perioperative care. <i>Lab. Anim.<\/i> 50: 264\u2013274.","DOI":"10.1177\/0023677216631458"},{"key":"8","unstructured":"8. Gades, N. M., Danneman, P. J., Wixson, S. K. and Tolley, E. A. 2000. The magnitude and duration of the analgesic effect of morphine, butorphanol, and buprenorphine in rats and mice. <i>Contemp. Top. Lab. Anim. Sci.<\/i> 39: 8\u201313."},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Gilsbach, R., R\u00f6ser, C., Beetz, N., Brede, M., Hadamek, K., Haubold, M., Leemhuis, J., Philipp, M., Schneider, J., Urbanski, M., Szabo, B., Weinshenker, D. and Hein, L. 2009. Genetic dissection of alpha2-adrenoceptor functions in adrenergic versus nonadrenergic cells. <i>Mol. Pharmacol.<\/i> 75: 1160\u20131170.","DOI":"10.1124\/mol.109.054544"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Haapalinna, A., Viitamaa, T., MacDonald, E., Savola, J. M., Tuomisto, L., Virtanen, R. and Heinonen, E. 1997. Evaluation of the effects of a specific \u03b1 2-adrenoceptor antagonist, atipamezole, on \u03b1 1- and \u03b1 2-adrenoceptor subtype binding, brain neurochemistry and behaviour in comparison with yohimbine. <i>Naunyn Schmiedebergs Arch. Pharmacol.<\/i> 356: 570\u2013582.","DOI":"10.1007\/PL00005092"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Hunter, J. C., Fontana, D. J., Hedley, L. R., Jasper, J. R., Lewis, R., Link, R. E., Secchi, R., Sutton, J. and Eglen, R. M. 1997. Assessment of the role of alpha2-adrenoceptor subtypes in the antinociceptive, sedative and hypothermic action of dexmedetomidine in transgenic mice. <i>Br. J. Pharmacol.<\/i> 122: 1339\u20131344.","DOI":"10.1038\/sj.bjp.0701520"},{"key":"12","unstructured":"12. Izer, J. M., Whitcomb, T. L. and Wilson, R. P. 2014. Atipamezole reverses ketamine-dexmedetomidine anesthesia without altering the antinociceptive effects of butorphanol and buprenorphine in female C57BL\/6J mice. <i>J. Am. Assoc. Lab. Anim. Sci.<\/i> 53: 675\u2013683."},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Jang, H. S. and Lee, M. G. 2009. Atipamezole changes the antinociceptive effects of butorphanol after medetomidine-ketamine anaesthesia in rats. <i>Vet. Anaesth. Analg.<\/i> 36: 591\u2013596.","DOI":"10.1111\/j.1467-2995.2009.00497.x"},{"key":"14","unstructured":"14. Janssen, C. F., Maiello, P., Wright, M. J. Jr., Kracinovsky, K. B. and Newsome, J. T. 2017. Comparison of atipamezole with yohimbine for antagonism of xylazine in mice anesthetized with ketamine and xylazine. <i>J. Am. Assoc. Lab. Anim. Sci.<\/i> 56: 142\u2013147."},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Kauppila, T., Jyv\u00e4sj\u00e4rvi, E., H\u00e4m\u00e4l\u00e4inen, M. M. and Pertovaara, A. 1998. The effect of a selective alpha2-adrenoceptor antagonist on pain behavior of the rat varies, depending on experimental parameters. <i>Pharmacol. Biochem. Behav.<\/i> 59: 477\u2013485.","DOI":"10.1016\/S0091-3057(97)00393-6"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Kawai, S., Takagi, Y., Kaneko, S. and Kurosawa, T. 2011. Effect of three types of mixed anesthetic agents alternate to ketamine in mice. <i>Exp. Anim.<\/i> 60: 481\u2013487.","DOI":"10.1538\/expanim.60.481"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Kirihara, Y., Takechi, M., Kurosaki, K., Kobayashi, Y. and Kurosawa, T. 2013. Anesthetic effects of a mixture of medetomidine, midazolam and butorphanol in two strains of mice. <i>Exp. Anim.<\/i> 62: 173\u2013180.","DOI":"10.1538\/expanim.62.173"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Kirihara, Y., Takechi, M., Kurosaki, K., Kobayashi, Y., Saito, Y. and Takeuchi, T. 2015. Anesthetic effects of a three-drugs mixture\u2014comparison of administrative routes and antagonistic effects of atipamezole in mice. <i>Exp. Anim.<\/i> 64: 39\u201347.","DOI":"10.1538\/expanim.14-0039"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Lakhlani, P. P., MacMillan, L. B., Guo, T. Z., McCool, B. A., Lovinger, D. M., Maze, M. and Limbird, L. E. 1997. Substitution of a mutant alpha2a-adrenergic receptor via \u201chit and run\u201d gene targeting reveals the role of this subtype in sedative, analgesic, and anesthetic-sparing responses in vivo. <i>Proc. Natl. Acad. Sci. USA<\/i> 94: 9950\u20139955.","DOI":"10.1073\/pnas.94.18.9950"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. L\u00e4hdesm\u00e4ki, J., Sallinen, J., MacDonald, E., Sirvi\u00f6, J. and Scheinin, M. 2003. Alpha2-adrenergic drug effects on brain monoamines, locomotion, and body temperature are largely abolished in mice lacking the alpha2A-adrenoceptor subtype. <i>Neuropharmacology<\/i> 44: 882\u2013892.","DOI":"10.1016\/S0028-3908(03)00080-7"},{"key":"21","unstructured":"21. Lamont, L. A. and Mathews, K. A. 2007. Opioids, nonsteroidal anti-inflammatories, and analgesic adjuvants. pp. 249\u2013251. In: Lumb &amp; Jones\u2019 Veterinary Anesthesia and Analgesia, 4th ed. (Tranquilli, W. J., Thurmon, J. C. and Grimm, K. A. eds.), Blackwell Publishing, Ames."},{"key":"22","unstructured":"22. Lemke, K. A. 2007. Anticholinergics and sedatives. pp. 210\u2013230. In: Lumb &amp; Jones\u2019 Veterinary Anesthesia and Analgesia, 4th ed. (Tranquilli, W. J., Thurmon, J. C. and Grimm, K. A. eds.), Blackwell Publishing, Ames."},{"key":"23","unstructured":"23. Naganuma, Y., Morii, K., Saitou, T., Hashimoto, M. and Koyama, H. 2013. Effect of medetomidine\/midazolam\/butorphanol in three mouse strains. <i>Exp. Anim.<\/i> 62  Supplement: S86."},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Ochiai, Y., Iwano, H., Sakamoto, T., Hirabayashi, M., Kaneko, E., Watanabe, T., Yamashita, K. and Yokota, H. 2016. Blood biochemical changes in mice after administration of a mixture of three anesthetic agents. <i>J. Vet. Med. Sci.<\/i> 78: 951\u2013956.","DOI":"10.1292\/jvms.15-0474"},{"key":"25","unstructured":"25. Okamura, T. 2016. Medetomidine\/midazolam\/butorphanol: a new anesthetic combination for mice. <i>LABIO21<\/i> 66: 5\u20139 (in Japanese)."},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Pertovaara, A., Haapalinna, A., Sirvi\u00f6, J. and Virtanen, R. 2005. Pharmacological properties, central nervous system effects, and potential therapeutic applications of atipamezole, a selective alpha2-adrenoceptor antagonist. <i>CNS Drug Rev.<\/i> 11: 273\u2013288.","DOI":"10.1111\/j.1527-3458.2005.tb00047.x"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Salonen, S., Vuorilehto, L., Vainio, O. and Anttila, M. 1995. Atipamezole increases medetomidine clearance in the dog: an agonist-antagonist interaction. <i>J. Vet. Pharmacol. Ther.<\/i> 18: 328\u2013332.","DOI":"10.1111\/j.1365-2885.1995.tb00599.x"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Tashiro, M., Hosokawa, Y., Amao, H. and Tohei, A. 2020. Duration of thermal support for preventing hypothermia induced by anesthesia with medetomidine-midazolam-butorphanol in mice. <i>J. Vet. Med. Sci.<\/i> 82: 1757\u20131762.","DOI":"10.1292\/jvms.20-0256"},{"key":"29","unstructured":"29. Thompson, J. S., Brown, S. A., Khurdayan, V., Zeynalzadedan, A., Sullivan, P. G. and Scheff, S. W. 2002. Early effects of tribromoethanol, ketamine\/xylazine, pentobarbitol, and isoflurane anesthesia on hepatic and lymphoid tissue in ICR mice. <i>Comp. Med.<\/i> 52: 63\u201367."},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Tsukamoto, A., Serizawa, K., Sato, R., Yamazaki, J. and Inomata, T. 2015. Vital signs monitoring during injectable and inhalant anesthesia in mice. <i>Exp. Anim.<\/i> 64: 57\u201364.","DOI":"10.1538\/expanim.14-0050"},{"key":"31","unstructured":"31. Urano, T., Ohwada, K., Kita, M., Kyuwa, S., Kunita, S., Hokao, R., Miyoshi, I., Yagami, K., Yamada, Y. and Watanabe, K. 2017. Individual standards on laboratory animal facilities. pp. 113, 132\u2013133. In: Handbook of the Standards Relating to the Care and Keeping and Reducing Pain of Laboratory Animals (in Japanese), Adthree, Tokyo. http:\/\/www.env.go.jp\/nature\/dobutsu\/aigo\/2_data\/pamph\/h2911.html [accessed on January 23, 2021]."},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. V\u00e4h\u00e4-Vahe, A. T. 1990. Clinical effectiveness of atipamezole as a medetomidine antagonist in cats. <i>J. Small Anim. Pract.<\/i> 31: 193\u2013197.","DOI":"10.1111\/j.1748-5827.1990.tb00770.x"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. V\u00e4h\u00e4-Vahe, A. T. 1990. The clinical effectiveness of atipamezole as a medetomidine antagonist in the dog. <i>J. Vet. Pharmacol. Ther.<\/i> 13: 198\u2013205.","DOI":"10.1111\/j.1365-2885.1990.tb00769.x"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Risbrough, V. B. and Geyer, M. A. 2005. Anxiogenic treatments do not increase fear-potentiated startle in mice. <i>Biol. Psychiatry<\/i> 57: 33\u201343.","DOI":"10.1016\/j.biopsych.2004.10.006"},{"key":"35","unstructured":"35. Virtanen, R., Savola, J. M. and Saano, V. 1989. Highly selective and specific antagonism of central and peripheral alpha 2-adrenoceptors by atipamezole. <i>Arch. Int. Pharmacodyn. Ther.<\/i> 297: 190\u2013204."},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Virtanen, R., Savola, J. M., Saano, V. and Nyman, L. 1988. Characterization of the selectivity, specificity and potency of medetomidine as an \u03b1 <sub>2<\/sub>-adrenoceptor agonist. <i>Eur. J. Pharmacol.<\/i> 150: 9\u201314.","DOI":"10.1016\/0014-2999(88)90744-3"},{"key":"37","unstructured":"37. Wellington, D., Mikaelian, I. and Singer, L. 2013. Comparison of ketamine-xylazine and ketamine-dexmedetomidine anesthesia and intraperitoneal tolerance in rats. <i>J. Am. Assoc. Lab. Anim. Sci.<\/i> 52: 481\u2013487."},{"key":"38","doi-asserted-by":"crossref","unstructured":"38. Zhu, Q., Gu, L., Wang, Y., Jia, L., Zhao, Z., Peng, S. and Lei, L. 2014. The role of alpha-1 and alpha-2 adrenoceptors in restraint stress-induced liver injury in mice. <i>PLoS One<\/i> 9: e92125.","DOI":"10.1371\/journal.pone.0092125"}],"container-title":["Journal of Veterinary Medical Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jvms\/84\/3\/84_21-0479\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,2]],"date-time":"2022-04-02T04:46:08Z","timestamp":1648874768000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jvms\/84\/3\/84_21-0479\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022]]},"references-count":38,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1292\/jvms.21-0479","relation":{},"ISSN":["0916-7250","1347-7439"],"issn-type":[{"value":"0916-7250","type":"print"},{"value":"1347-7439","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022]]},"article-number":"21-0479"}}